According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -โน486.57. In 2022 the company made an earnings per share (EPS) of -โน363.43 a decrease over its 2021 EPS that were of -โน242.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน467.12 | 28.53% |
2022 | -โน363.43 | 50.18% |
2021 | -โน242.00 | 40.8% |
2020 | -โน171.88 | -4.74% |
2019 | -โน180.43 | 8.21% |
2018 | -โน166.75 | -24.12% |
2017 | -โน219.77 | -776.32% |
2016 | โน32.50 | -139.18% |
2015 | -โน82.95 | 125.58% |
2014 | -โน36.77 | -67.67% |
2013 | -โน113.73 | -44.58% |
2012 | -โน205.23 | -44.95% |
2011 | -โน372.84 | -6.84% |
2010 | -โน400.20 | -290.24% |
2009 | โน210.36 | -135.96% |
2008 | -โน584.91 | 10.68% |
2007 | -โน528.48 | -33.97% |
2006 | -โน800.41 | 5.41% |
2005 | -โน759.36 | -60.64% |
2004 | -โน1,929 | -77.21% |
2003 | -โน8,466 |